Acne Cleanser
FDA Label NDC 50157-021

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Brands International for the product Acne Cleanser (NDC 50157-021). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, otc - keep out of reach of children, dosage & administration, warnings, other safety information, inactive ingredient, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active Ingredient Purpose

Salicylic Acid 1% ............Acne Treatment

Otc - Purpose

for the treatment of Acne

Indications & Usage

clears up acne blemishes, blackheads and whiteheads

penetrates pores to control acne blemishes

helps prevent new acne blemishs from forming

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.  If swallowed, get medical help or contact a Poison Control Center right away.

Dosage & Administration

Wet face

Squeeze product into hands

massage over entire face

rinse thoroughly

for optimal results use up to 2-3 times per week

Warnings

Warning: for external use only. skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time.

When using this product avoid contact with eyes. If contact occurs, flush thoroughly with water.

Other Safety Information

Store at room temparture

Inactive Ingredient

Inactive Ingredients:water, cocamidopropyl betaine, propylene glycol, sodium chloride, fragrance, Tetra sodium EDTA, aloe barbadensis leaf extract, methylchloroisothiazolinone, methylisothiazoline,

Package Label.Principal Display Panel

2 (2)

2 (2)

1 (1)

1 (1)

* Please review the disclaimer below.